Your browser doesn't support javascript.
loading
Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke.
Eldahshan, Wael; Sayed, Mohammed A; Awad, Mohamed E; Ahmed, Heba A; Gillis, Ellen; Althomali, Waleed; Pillai, Bindu; Alshammari, Abdulkarim; Jackson, Ladonya; Dong, Guangkuo; Sullivan, Jennifer C; Cooley, Marion A; Elsalanty, Mohammed; Ergul, Adviye; Fagan, Susan C.
Afiliação
  • Eldahshan W; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Sayed MA; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Awad ME; Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Ahmed HA; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America.
  • Gillis E; Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Althomali W; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Pillai B; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Alshammari A; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Jackson L; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Dong G; Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Sullivan JC; Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Cooley MA; Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Elsalanty M; Department of Medical Anatomical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Medical Sciences, Pomona, CA, United States of America.
  • Ergul A; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States of America; Ralph H. Johnson VA Medical Center, Charleston, SC, United States of America.
  • Fagan SC; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America. Electronic address: sfagan@augusta.edu.
Vascul Pharmacol ; 141: 106904, 2021 12.
Article em En | MEDLINE | ID: mdl-34481068

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Angiotensina / Acidente Vascular Cerebral Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Angiotensina / Acidente Vascular Cerebral Idioma: En Ano de publicação: 2021 Tipo de documento: Article